How investors can be fooled by development costs




MoneyWeek Investment Tutorials Podcast show

Summary: Biotech and pharmaceutical investors, amongst others, need to watch out for the way firms treat the cost of developing new products as this can have a big impact on a firm's results. In his fifth video in the "cooking the books" series Tim Bennett explains how.